Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMBQAKO)

Drug Name

PMID20471253C32 Drug Info

Synonyms

GTPL8184; BDBM50319716; 3ND

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Rho-associated protein kinase 2 (ROCK2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
KD025	DM548TK	Psoriasis vulgaris	EA90	Phase 2	[2]
INS-117548	DMA46DO	Glaucoma/ocular hypertension	9C61	Phase 1	[3]
GSK269962A	DM5I2HL	Inflammation	1A00-CA43.1	Clinical trial	[4]
PMID28048944-Compound-19	DMPT3V9	N. A.	N. A.	Patented	[5]
PMID28048944-Compound-3	DM1BN74	N. A.	N. A.	Patented	[5]
PMID28048944-Compound-7	DMXZ368	N. A.	N. A.	Patented	[5]
PMID28048944-Compound-4	DMJAUWG	N. A.	N. A.	Patented	[5]
PMID28048944-Compound-5	DMAB987	N. A.	N. A.	Patented	[5]
PMID28048944-Compound-6	DM5RCBV	N. A.	N. A.	Patented	[5]
PMID28048944-Compound-2	DM9ZXOP	N. A.	N. A.	Patented	[5]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Protein kinase G2 (PRKG2)	TTDWFCQ	KGP2_HUMAN	Inhibitor	[1]
Protein kinase N2 (PKN2)	TTTHO0M	PKN2_HUMAN	Inhibitor	[1]
Rho-associated protein kinase 2 (ROCK2)	TTGWKQJ	ROCK2_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3746-9.
2	Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16814-9.
3	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
4	Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther. 2007 Jan;320(1):89-98.
5	Rho kinase inhibitors: a patent review (2014 - 2016).Expert Opin Ther Pat. 2017 Apr;27(4):507-515.